Cancer is challenging to treat, yet identifying individuals with greater risk of developing disease can assist with early detection and increased treatment efficacy. There are several types of risk ...
A polygenic risk score was able to detect a high proportion of clinically significant prostate cancer. Cancer would not have been detected in 71.8% of patients with the use of PSA or MRI screening.
Incorporating a polygenic risk score into prostate cancer screening could enhance the detection of clinically significant prostate cancer that conventional screening may miss, according to results of ...
A polygenic risk score (PRS) may help identify women who are at a greater risk of developing a future breast cancer after treatment for in situ breast disease, a retrospective study suggests. The ...
Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...
Evaluating the impact of long-term glucocorticoid use on cancer risk in patients with rheumatologic diseases: A retrospective cohort study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
Bottom Line: In a retrospective study, the 313-SNP breast cancer polygenic risk score (PRS 313) blood test could predict future incidents of breast cancer in women diagnosed with ductal carcinoma in ...
The blood or saliva test results can be used as a “risk enhancer” for patients who fall in treatment gray zones, study author ...
What sets this test apart is its scope: rather than running separate tests for each condition, it pulls together risk ...
Many risk factors for cardiovascular conditions exist, including inherited factors. Now, a validation study suggests a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results